Giant Biogene Holding Co., Ltd. (HKG:2367)
Hong Kong · Delayed Price · Currency is HKD 25.52
-0.20 (-0.78%)
Jun 18, 2026, 4:08 PM HKT
Giant Biogene Holding Stock Forecast
Stock Price Forecast
According to 18 analysts polled by S&P Global, Giant Biogene Holding stock has a consensus rating of "Strong Buy" and an average price target of $42.99. The average 1-year stock price forecast is 68.46% higher than the current stock price, while the lowest is $33.40 (+30.88%) and the highest is $82.20 (+222.10%).
Price Target: $42.99 (+68.46%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Giant Biogene Holding stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 16 | 15 | 14 | 14 | 14 | 14 |
| Buy | 3 | 3 | 3 | 1 | 1 | 1 |
| Hold | 2 | 2 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 21 | 20 | 20 | 18 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst UBS No rating | UBS | Hold Maintains $34.00 | Hold | Maintains | $34.00 | +33.23% | May 26, 2026 |
Unknown Analyst Guotai Haitong No rating | Guotai Haitong | Buy Maintains $36.20 | Buy | Maintains | $36.20 | +41.85% | Apr 28, 2026 |
Unknown Analyst Huatai Securities No rating | Huatai Securities | Buy Maintains $45.00 | Buy | Maintains | $45.00 | +76.33% | Apr 23, 2026 |
Unknown Analyst Citic Securities No rating | Citic Securities | Buy Maintains $40.00 | Buy | Maintains | $40.00 | +56.74% | Apr 22, 2026 |
Unknown Analyst Morgan Stanley No rating | Morgan Stanley | Buy Maintains $43.00 | Buy | Maintains | $43.00 | +68.50% | Apr 20, 2026 |
Financial Forecast
Revenue This Year
6.15B
from 5.52B
Increased by 11.51%
Revenue Next Year
7.00B
from 6.15B
Increased by 13.80%
EPS This Year
2.10
from 2.11
Decreased by -0.50%
EPS Next Year
2.31
from 2.10
Increased by 10.12%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 7.6B | ||
| Avg | 6.2B | ||
| Low | 5.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 38.4% | ||
| Avg | 11.5% | ||
| Low | 6.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.15 | ||
| Avg | 2.10 | ||
| Low | 2.03 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.8% | ||
| Avg | -0.5% | ||
| Low | -3.8% |